Hongying Cao

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study

Christina Fotopoulou, Tabassum Khan, Juraj Bracinik et al. · American Journal of Obstetrics and Gynecology · 2022 · 61 citations · Full text

Medicine, Oncology, Surgery +6

RETRACTED: Knockdown of lncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b

Pengmu Xie, Hongying Cao, Ying Li et al. · Cancer Biomarkers · 2017 · 56 citations · Full text

Medicine, Cancer Biology, Oncology +14

<p>Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer</p>

Xiangyu Zhang, Zelai He, Longquan Xiang et al. · Drug Design Development and Therapy · 2019 · 44 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Tetrahydrocurcumin is more effective than curcumin in inducing the apoptosis of H22 cells via regulation of a mitochondrial apoptosis pathway in ascites tumor-bearing mice

Weihai Liu, Zhenbiao Zhang, Guosheng Lin et al. · Food & Function · 2017 · 43 citations

Medicine, Oncology, Pharmacology +13